Skip to main content
PMC home page
Cellular and Molecular Immunology logoLink to Cellular and Molecular Immunology
. 2022 May 13;19(6):754. doi: 10.1038/s41423-022-00860-7

Correction to: Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1

Chaohu Pan 1,2,#, Qiaomei Cai 3,#, Xiaorong Li 3, Lili Li 3, Liping Yang 2,4, Yu Chen 1,2, Junxiao Liu 3, Wancheng Liu 3, Meiling Gao 3, Tianqi Sui 1,2, Xiaoyang Wang 5, Huiming Fan 3, Jiayin Ruan 3, Yueyue Shi 3, Saihua Chen 6, Lucy S Cheng 7, Jiayong Liu 8,✉, Heng Yang 3,✉, Genhong Cheng 9,✉
PMCID: PMC9151714  PMID: 35562553

Correction to: Cellular and Molecular Immunology 10.1038/s41423-021-00824-3, published online 05 January 2022

In the version of this article initially published, a grant name and the acknowledgment information were missing. The grant name and acknowledgment information have been added at the end of Acknowledgments: J.L. is supported by WU Jieping Medical Foundation (320.6750.2021-17-12). We thank Dr. Chunfu Zheng for providing the HSV-1 BAC plasmid. The results and conclusions were not affected.

Contributor Information

Jiayong Liu, Email: liujiayong_doc@163.com.

Heng Yang, Email: yhmyt@hotmail.com.

Genhong Cheng, Email: gcheng@mednet.ucla.edu.

Articles from Cellular and Molecular Immunology are provided here courtesy of Nature Publishing Group

RESOURCES